is glp-1 safe for kidneys Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease RACGP - GLP-1 receptor agonists

These medications work by mimicking the action of naturally occurring GLP-1, an incretin hormone produced in the intestine that regulates blood glucose levels and appetite

Four of six exons encode separate functional domains of rat pre-proglucagon

Nystrom T: The potential beneficial role of glucagon-like peptide-1 in endothelial dysfunction and heart failure associated with insulin resistance

The observation that oral versus intravenous glucose administration produced a stronger insulin response is at the core of the incretin effect, defined as the difference in pancreatic -cell insulin secretory response to glucose administered orally or intravenously [21]

Additionally, tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis

However, even small increases in GLP-1 levels achieved by enhanced secretion or slowed degradation can have significant effects on glucose homeostasis, appetite regulation, and gastrointestinal motility